Gary Nachman – Raymond James

Raymond James

A Raymond James analyst with 18 tracked ratings across 15 distinct tickers has issued 10 bullish ratings and holds a 46.2% success rate on the captured sample, covering multiple sectors.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

7 months ago

2025-10-30 00:00:00+00

Track record

Aggregated

46% success rate

Bullish: 0
Hold: 0
Bearish: 0

Aggregated

Not available

Bullish: 10
Hold: 2
Bearish: 0

Recent ratings

Ticker	Date	Rating	Price target	Source
BLCO	2025-10-30	buy	$19.00	Aggregated
BLCOBAUSCH + LOMB CORP	2025-10-30	unknown	$19.00	Aggregated
IONS	2025-10-30	buy	$89.00	Aggregated
IONSIONIS PHARMACEUTICALS INC	2025-10-30	unknown	$89.00	Aggregated
LENZ	2025-10-20	buy	$50.00	Aggregated
LENZLENZ THERAPEUTICS INC.	2025-10-20	unknown	$50.00	Aggregated
ABBV	2025-10-17	buy	$250.00	Aggregated
AMGN	2025-09-03	hold	-	Aggregated
VERU	2025-08-13	buy	$20.00	Aggregated
VERUVERU INC	2025-08-13	unknown	$20.00	Aggregated
LENZ	2025-07-31	buy	$40.00	Aggregated
ABBVABBVIE INC	2025-04-28	unknown	$227.00	Aggregated
ACHV	2024-09-27	buy	$20.00	Aggregated
ACHVACHIEVE LIFE SCIENCES INC.	2024-09-27	unknown	$20.00	Aggregated
LENZ	2024-09-27	buy	$37.00	Aggregated
PCRXPACIRA BIOSCIENCES INC	2024-07-31	unknown	$37.00	Aggregated
AMGN	2024-03-28	hold	-	Aggregated
AQST	2024-03-28	buy	$7.00	Aggregated
VERU	2024-03-28	buy	$3.00	Aggregated
ALNYALNYLAM PHARMACEUTICALS INC	2023-09-29	unknown	$208.00	Aggregated

Tickers covered(16)

Ticker	Ratings	Last rating	Sources
BLCO	1	2025-10-30	Aggregated
BLCOBAUSCH + LOMB CORP	1	2025-10-30	Aggregated
IONS	1	2025-10-30	Aggregated
IONSIONIS PHARMACEUTICALS INC	1	2025-10-30	Aggregated
LENZ	3	2025-10-20	Aggregated
LENZLENZ THERAPEUTICS INC.	1	2025-10-20	Aggregated
ABBV	1	2025-10-17	Aggregated
AMGN	2	2025-09-03	Aggregated
VERU	2	2025-08-13	Aggregated
VERUVERU INC	1	2025-08-13	Aggregated
ABBVABBVIE INC	1	2025-04-28	Aggregated
ACHV	1	2024-09-27	Aggregated
ACHVACHIEVE LIFE SCIENCES INC.	1	2024-09-27	Aggregated
PCRXPACIRA BIOSCIENCES INC	1	2024-07-31	Aggregated
AQST	1	2024-03-28	Aggregated
ALNYALNYLAM PHARMACEUTICALS INC	1	2023-09-29	Aggregated

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.